Category
Health
60 news items
Abbott Device Aids Premature Infant with Heart Defect
Anthony "Little Tony" Daly, born 14 weeks premature, survived a heart defect using an Abbott device. Now 10, he is helping launch a new heart health community.
17 July 2026
Scientists Name Abbott a Top Employer
Abbott Laboratories has been recognized as a top employer by the scientific community, appearing on Science Magazine's list for the 15th consecutive year.
17 July 2026
Abbott's Leadless Pacemaker Allows Professional Surfer to Resume Career
Abbott Laboratories' AVEIR DR system implantation has enabled professional surfer Mikey DeTemple to resume his sport following a heart condition.
17 July 2026
Chinese ALS Drug Completes Phase 2 Trials, Eyes Market Next Year
A domestic Chinese drug targeting SOD1 gene mutations in ALS patients has successfully completed its Phase 2 clinical trials. Influential in its development was ALS patient Cai Lei, with market launch anticipated next year.
17 July 2026
Ananda Pharma Doses First Patient in Peripheral Neuropathy Trial
Ananda Pharma Limited has administered the first dose in its ACTiON clinical trial, investigating a CBD-based drug candidate, MRX1, for chemotherapy-induced peripheral neuropathy (CIPN).
17 July 2026
EQL Pharma AB Announces Annual General Meeting
EQL Pharma AB has announced its annual general meeting will be held on Thursday, August 20, 2026, at its premises in Lund. Shareholders will vote on board appointments and company matters.
17 July 2026
ADMA Biologics Class Action Lawsuit Deadline Looms for Investors
Investors in ADMA Biologics who experienced substantial losses between August 2024 and March 2026 have an opportunity to lead a class action lawsuit.
17 July 2026
Blood Test May Predict Alzheimer's Risk Years Before Symptoms Appear
New research suggests blood tests detecting two proteins can forecast cognitive decline up to a decade in advance. Findings could enable earlier interventions and improve trial candidate selection.
17 July 2026
Getinge Reports Strong Second Quarter Driven by High Profitability
Medical technology company Getinge announced its second-quarter results, showing strong organic growth, high profitability, and robust cash flow. The results were positively impacted by factors including a tariff refund and operational improvements.
17 July 2026Qlife Holding AB: Business Update for First Half of 2026
Qlife Holding AB has provided a business update for the first half of 2026. The company advanced strategic partnerships and the development of its Egoo Health platform.
17 July 2026
Novomatic Hosts 7th Annual Health Day for Employees
NOVOMATIC AG held its 7th annual health and wellness event at its headquarters in Gumpoldskirchen, attracting over 1,000 employees. The event focused on promoting employee health and safety as part of the company's ongoing well-being initiative. Local officials attended to acknowledge the company's regional contribution.
17 July 2026
US FDA accepts Camurus' CAM2029 resubmission for acromegaly for review
The US Food and Drug Administration (FDA) has accepted for review Camurus' resubmitted New Drug Application (NDA) for CAM2029, a treatment for acromegaly.
17 July 2026FDA Accepts Camurus' CAM2029 for Acromegaly Review
The U.S. Food and Drug Administration (FDA) has accepted a resubmitted New Drug Application for Camurus' CAM2029, an extended-release octreotide injection for acromegaly treatment. A decision is expected by December 18, 2026.
17 July 2026FDA Accepts Camurus' CAM2029 Application for Review
The U.S. Food and Drug Administration (FDA) has accepted for review Camurus' resubmitted New Drug Application (NDA) for CAM2029. The agency has set a target action date of December 18, 2026.
17 July 2026
Neurizon ALS Trial Completes Enrolment Ahead of Schedule
Neurizon Therapeutics has completed patient enrolment for its NUZ-001 drug candidate in the HEALEY ALS Platform Trial in under five months.
17 July 2026
Robotic Surgery Drives Growth in Healthcare Systems
Robotic-assisted surgery (RAS) has seen significant growth over the past decade, reducing open procedures and improving patient outcomes. Two U.S. health systems share their experiences with the da Vinci surgical system.
17 July 2026
Intuitive clarifies communication on surgical system power performance
Intuitive has issued a clarification regarding a December 2024 communication to US customers, addressing the performance of da Vinci 5 surgical systems during power interruptions.
17 July 2026
Guerbet publishes 2022 Universal Registration Document
French medical imaging company Guerbet has released its official Universal Registration Document for 2022. The filing provides a comprehensive overview of the company's operations, financial data, and governance.
17 July 2026Singapore General Hospital Offers Lecture on PTSD for Healthcare Professionals
Singapore General Hospital (SGH) held a complimentary webinar on May 25, 2022, focusing on Post Traumatic Stress Disorder (PTSD) as part of its Understanding Mental Illnesses series.
17 July 2026
Singapore General Hospital recognised for surgical quality
Singapore General Hospital (SGH) has received recognition from the American College of Surgeons for its improved surgical quality standards. The hospital is now among the world's leading institutions for surgical patient care.
17 July 2026History of Medical Education in Singapore
Singapore General Hospital (SGH) has historically served as a cornerstone for medical education in Singapore, originating from the establishment of its first medical school in 1905.
17 July 2026
Singapore-Developed Device Aims to Improve Seniors' Muscle Strength
Singapore General Hospital supports wider access to QMT, a device approved for medical use that can enhance muscle strength and mobility in the elderly, potentially reducing falls and fractures.
17 July 2026
Tampa General Hospital First to Sign "Food is Medicine" Pledge
Tampa General Hospital has become the first hospital in the nation to officially commit to prioritizing nutrition in patient care by signing the "Make Hospital Food Healthy Again" pledge.
17 July 2026
German Pharma Industry Calls for Action to Maintain Competitiveness
Germany's industrial health sector, contributing over 100 billion euros in gross value, faces international competition. The IGBCE union and eight pharmaceutical companies propose six action points to strengthen innovation.
17 July 2026
Law Firm Investigates Claims Against HCA Healthcare Investors
Pomerantz LLP is investigating potential securities fraud claims against HCA Healthcare, Inc. The inquiry follows the company's reduced profit guidance and a subsequent drop in its stock price.
16 July 2026
Pomerantz Law Firm Investigates Claims Against Celcuity Inc. Investors
Pomerantz LLP is investigating claims on behalf of investors of Celcuity Inc. The inquiry concerns whether the company and its officers engaged in securities fraud or unlawful business practices.
16 July 2026
First Lawsuit Filed in 2026 Multistate Cyclospora Outbreak Against Taco Bell Operator
Food safety attorneys have filed the first lawsuit related to the 2026 multistate Cyclospora outbreak. The plaintiff claims to have fallen ill after eating at a Taco Bell in Ohio.
16 July 2026
CopperJoint Releases Guide on Low-Impact Cardio for Ankle Injuries
CopperJoint, LLC has published a guide detailing 12 low-impact exercises designed for individuals managing or preventing ankle injuries. The aim is to strengthen the ankle and improve its stability.
16 July 2026
Two Trump Health Nominees Fail Senate Confirmation Hearing
Two nominees for high-profile health roles in the Trump administration faced significant opposition in a Senate hearing on Wednesday. Both candidates, Erica Schwartz and Sean Kaufman, appeared to falter under questioning.
16 July 2026Nanobiotix Reports First Half 2025 Financial Results and Business Update
Biotechnology company Nanobiotix has released its H1 2025 financial results and provided an operational progress update, highlighting advancements in its cancer therapeutic development and clinical trials.
16 July 2026
Nanobiotix Advances Nanoprimer Platform for Drug Delivery
Nanobiotix announced advancements for its Curadigm Nanoprimer platform, designed to improve the delivery of intravenously administered drugs to target tissues. The company has filed four new patent applications and presented preclinical data.
16 July 2026Nanobiotix Secures Royalty Financing, Reports Q3 2025 Update and Clinical Outlook
Biotechnology firm Nanobiotix has secured a royalty financing deal worth up to $71 million and provided an update on its Q3 2025 operations, highlighting progress in its JNJ-1900 (NBTXR3) cancer treatment development.
16 July 2026
Top 5 Manufacturers of Automated Liquid Handlers Identified
A new analysis from Roots Analysis identifies five key companies manufacturing automated liquid handling systems, responding to growing demand in the biopharmaceutical sector.
16 July 2026Roots Analysis Identifies Top 10 Fermenter and Bioreactor Manufacturers
A new market analysis names the ten leading companies in fermenter and bioreactor manufacturing, crucial for addressing capacity constraints and meeting growing demand in the biopharmaceutical sector.
16 July 2026Roots Analysis Identifies Nine Leading ADC Technology Providers
Market research firm Roots Analysis has released a report identifying nine key players providing linker and conjugation technologies for antibody drug conjugate (ADC) development.
16 July 2026
Molina Healthcare to Join S&P MidCap 400 Index
Molina Healthcare (NYSE: MOH) will be added to the S&P MidCap 400 index, replacing National Storage Affiliates Trust, effective July 22, 2026. Construction Partners Inc. (NASD: ROAD) will join the S&P SmallCap 600.
16 July 2026
Lifebanc Reports Nearly 300 Lives Saved Through Organ Donation in First Half of 2026
Lifebanc, an organ procurement organization in Northeast Ohio, reported nearly 300 lives saved by organ donation in the first half of 2026. This marks a 5% increase over the same period last year.
16 July 2026
MedStar Georgetown Transplant Surgeon Selected as President-Elect of The Transplantation Society
Gabriel Gondolesi, MD, director at MedStar Georgetown Transplant Institute, has been named president-elect of The Transplantation Society (TTS). He is the organization's first president-elect from Latin America.
16 July 2026
Trellis Bioscience Raises $9 Million for Clinical Trials
Biotechnology company Trellis Bioscience has secured $9 million in funding to advance clinical development of a novel therapy for prosthetic joint infections.
16 July 2026
KINTAI Biotech Compares Cytisine and Varenicline for Smoking Cessation
KINTAI Biotech Inc. has analyzed the effectiveness and cost-effectiveness of cytisine versus varenicline for smoking cessation. The company suggests naturally sourced cytisine offers advantages.
16 July 2026
ROMTech Delayed Revenue to Strengthen Home Rehabilitation Services
ROMTech, a provider of remote orthopedic rehabilitation devices, deliberately slowed its growth in 2025 to enhance operational infrastructure and clinical oversight.
16 July 2026
Boehringer Ingelheim Certified for Human-Animal Bond Commitment
Boehringer Ingelheim has been recognized as a Human-Animal Bond Certified Company by NAVC and HABRI. The certification acknowledges the company's dedication to supporting the human-animal bond through education and research.
16 July 2026
Vanda Pharmaceuticals Receives EMA Positive Opinion for Orphan Drug Designation of Imsidolimab
Vanda Pharmaceuticals announced that the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products has adopted a positive opinion recommending orphan drug designation for imsidolimab for the treatment of generalized pustular psoriasis (GPP).
16 July 2026
Frederick Massage Therapist Reopens Practice
Frederick-based massage therapist Liz Guffey has reopened Serenity Space Massage Therapy after a six-month interruption due to relocation. The practice focuses on personalized care and client well-being.
16 July 2026
Cyclospora parasite causes diarrhea outbreak across U.S.
A widespread diarrhea outbreak caused by the cyclospora parasite is spreading across the U.S., challenging containment efforts due to the complex food supply chain. Over 1,600 cases have been confirmed.
16 July 2026
Zoetis Inc. Investors Offered Lead Role in Securities Fraud Class Action
Zoetis Inc. (ZTS) shareholders who experienced financial losses have been given an opportunity to lead a class action lawsuit alleging securities fraud. The lawsuit claims the company misrepresented its business prospects.
16 July 2026
Embecta Corp. Shareholders Offered Chance to Lead Securities Fraud Lawsuit
Embecta Corp. (NASDAQ: EMBC) shareholders who lost money have the opportunity to lead a securities fraud class action lawsuit. The complaint alleges the company's guidance was misleading.
16 July 2026
Apotex Receives Investment Grade Rating, Amends Credit Agreement
Canadian pharmaceutical company Apotex Health Corp. has secured an investment grade issuer rating from Morningstar DBRS and amended its credit agreement to lower borrowing costs and enhance financial flexibility.
16 July 2026
Drug-Free World Initiative Distributes Fentanyl Awareness Materials at World Cup Host Cities
The Foundation for a Drug-Free World is distributing informational booklets about fentanyl dangers in all host cities for the North American FIFA World Cup. The campaign has already distributed over 3 million booklets.
16 July 2026
AstraZeneca and Daiichi Sankyo partner on new antibody drug conjugate
AstraZeneca and Daiichi Sankyo have initiated a global agreement to develop and commercialize DS-1062, a new antibody drug conjugate targeting the TROP2 protein for cancer treatment.
16 July 2026
Enhertu shows 72% reduction in progression or death risk versus T-DM1 in HER2-positive breast cancer
AstraZeneca and Daiichi Sankyo's Enhertu significantly reduced the risk of disease progression or death by 72% compared to trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer patients in the DESTINY-Breast03 trial.
16 July 2026AstraZeneca and ArcherDX to use personalized assays for minimal residual disease detection in lung cancer
AstraZeneca is collaborating with ArcherDX to employ personalized cancer monitoring assays to detect minimal residual disease in patients with early-stage lung cancer.
16 July 2026AstraZeneca's Enhertu approved in China for advanced gastric cancer
China's National Medical Products Administration has granted conditional approval for AstraZeneca and Daiichi Sankyo's Enhertu to treat patients with previously treated HER2-positive advanced or metastatic gastric cancer.
16 July 2026
Cadient Launches AI Talent Registry for Healthcare Employers
Cadient has introduced SmartRegistry™, an AI-powered talent registry designed to help healthcare employers proactively identify qualified clinicians before the recruitment process begins.
16 July 2026
Icarus Behavioral Health Nevada Names Vonzella Jenkins Executive Director
Icarus Behavioral Health Nevada has appointed Vonzella Jenkins as its new executive director. Jenkins was promoted internally after serving as operations lead for the treatment center.
16 July 2026
Let Mommy Sleep Founder to Present on Gaps in Newborn Care Oversight
Let Mommy Sleep founder Denise Iacona Stern will present research on the lack of oversight in U.S. in-home newborn care at the Cribs for Kids National Safe Sleep Conference, advocating for industry standardization.
16 July 2026
Physician Administers First U.S. Infusion of Newly Approved Thyroid Eye Disease Treatment
Raymond Douglas, MD, PhD, has administered the first U.S. infusion of LUMVOA™ (veligrotug-vvze), a new FDA-approved treatment for Thyroid Eye Disease.
16 July 2026
Wellness Founder Faces Charges for Alleged Unlicensed GLP-1 Sales
Asheville-based wellness founder Priscilla Hendrix has been indicted on multiple felony charges, including practicing medicine without a license and obtaining property by false pretenses, related to sales of GLP-1 injections.
16 July 2026Flerie publishes merger document with Biosergen
Flerie AB and Biosergen have adopted a merger plan where Biosergen will be absorbed by Flerie. Biosergen's operations will be transferred to a new Flerie subsidiary.
16 July 2026
Buenos Aires Reduces Speeding to Improve Road Safety
Buenos Aires has implemented traffic calming measures on Saénz Avenue to reduce speeding and enhance pedestrian safety, following a study that identified high incident rates.
16 July 2026